US Archives - Page 16 of 119 - European Medical Journal

Current Approaches to Recurrent and Metastatic Cervical Cancer

Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…

Novel Pharmacology Curriculum in Hematology-Oncology Fellowship Program

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…

ASCO 2025: Highlights in Breast Cancer Research

THE theme of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting was ‘Driving Knowledge to Action: Building a Better…

High-Grade Gallbladder Neuroendocrine Tumor in a Young Female

Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…

Fertility Outcomes After Immunotherapy in Young Adults

Immune checkpoint inhibitors (ICI) are used to treat multiple types of cancer. However, there are limited studies on the long-term…

Prolonged Survival in Fibrolamellar HCC Treatment

Liver cancer is a leading global health concern, ranking as the sixth most common cancer and the third deadliest in 2022, with over…

ASCO 2025: Evolving Standards in Gastrointestinal Cancers

THIS year’s American Society of Clinical Oncology (ASCO) 2025 gastrointestinal (GI) sessions presented pivotal data across different GI…

Survival Disparities in Epithelial Ovarian Cancer

Ovarian cancer represents a leading cancer-related cause of death among women in the USA, with approximately 20,890 new cases expected to…

Navigators and Racial Literacy in Cervical Cancer Care

Cervical cancer is the third most prevalent cancer in Brazilian women. Around 17,000 new cases are expected for Brazil’s 2023–2025…

ASCO 2025 Interview: Melissa Hudson

I began working at the St. Jude Children’s Research Hospital’s After Completion of Therapy Clinic (Memphis, Tennessee, USA) in the early…